drugset / Trial / NCT00440076
Velcade in Myelodysplastic Syndrome - Pilot Study
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This is a four-center open-label study designed to determine activity of Velcade in Myelodysplastic Syndrome (MDS) patients. A total of 28 subjects will be enrolled. The patients will be registered to GIMEMA Data Center before therapy starts and after inclusion criteria verification.
Timeline
- Start
- 2006-08
- Primary completion
- —
- Completion
- 2008-03
Outcome
Outcome not reported
Stopped (Enrollment): “Low accrual”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bortezomib | Small molecule | — | — |